Aspire Medical, Inc.
Aspire Medical, Inc., (Aspire Medical), a privately-held medical device company, is engaged in the development and commercialization of minimally invasive treatments for obstructive sleep apnea (OSA). The company provides Advance System, an implantable medical device designed to treat tongue base obstruction for patients with obstructive sleep apnea. It started a first implant in the US and clinical trial to treat sleep apnea. Aspire Medical is supported by a premier group of venture capital investors including Three Arch Partners and New Leaf Venture Partners. Aspire Medical is headquartered at California, United States.